ClinConnect ClinConnect Logo
Search / Trial NCT06701890

Observational Study of Travellers Pathologies

Launched by INSTITUT PASTEUR · Nov 20, 2024

Trial Information

Current as of September 07, 2025

Recruiting

Keywords

Travel Risk Factors Pathology Arbovirose

ClinConnect Summary

This clinical trial is focused on understanding health problems that travelers may face when visiting emerging countries. These health issues can include stomach and lung infections, malaria, and accidents. By studying these problems, researchers hope to identify the risks associated with travel and develop better advice to help keep travelers safe and healthy.

To participate in this study, you need to be at least 18 years old, own a smartphone that can be used for data collection, and be preparing to travel outside of mainland France. You also need to be covered by social security or private insurance and willing to take part in the study. Participants will be asked to share their experiences and health during their travels, which will help researchers understand how to reduce travel-related illnesses. It's important to note that this study is not yet recruiting participants, so there is still time to consider if you meet the eligibility criteria before it begins.

Gender

ALL

Eligibility criteria

  • 1. Inclusion Criteria :
  • 1. For all participants in the EOP study :
  • Major subject (age ≥ 18)
  • Owns a smartphone compatible with electronic data collection
  • Preparing to travel outside mainland France
  • Affiliated with or covered by Social Security or private insurance
  • Willing to participate in the EOP study
  • 2. For the EOP-Arbo Sub-study :
  • - Subject who has consented to participate in the EOP_Arbo study.
  • 3. For the EOP-AMR Sub-study :
  • Subject who has consented to participate in the EOP_AMR study.
  • 2. Exclusion Criteria:
  • 1. For all participants in the EOP study :
  • Travel duration ≤ 3 days
  • Travel duration \> 12 months
  • Person traveling as part of an expatriation without planned movement outside the settlement in the destination country
  • Person under legal protection or unable to express consent for participation
  • 2. For the EOP-Arbo Sub-study :
  • - Individuals deemed clinically and/or biologically unfit by the investigator to undergo the blood samples required for the study.
  • 3. For the EOP-AMR Sub-study :
  • No specific exclusion criteria.

About Institut Pasteur

Institut Pasteur is a renowned global research organization dedicated to advancing biomedical science and public health. Established in 1887, it has a rich history of groundbreaking contributions to the understanding and prevention of infectious diseases. The institute conducts innovative clinical trials aimed at developing vaccines, diagnostics, and therapeutic strategies to combat a wide range of health threats. With a multidisciplinary approach and a commitment to collaboration, Institut Pasteur plays a pivotal role in translating scientific discoveries into tangible health solutions, thereby enhancing global health security and improving patient outcomes.

Locations

Paris, , France

Patients applied

0 patients applied

Trial Officials

Fabien TAIEB, MD

Principal Investigator

Medical Center of Institut Pasteur

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported